Louise van der Weerd1
The
development of molecular imaging techniques for in vivo assessment of
beta-amyloid accumulation in the ageing brain is an important and active area
of research in AD. Numerous ligands have been developed with affinity for
beta-amyloid, based on beta-amyloid peptide, monoclonal antibody fragments,
or small peptides, which were functionalized with iron oxide particles or
gadolium chelates. Alternatively, amyloid plaques have been labeled with
small molecules containing a 19F atom and visualized using 19F MRI. Up to
now, the only compounds that are in use for clinical imaging are nuclear
medicinebased amyloid labeling tracers.
CLINICAL INTENSIVE COURSE
(Admission limited to Clinical
Intensive Course registrants only)
Shoulder & Elbow Imaging: Case-Based Teaching